179 related articles for article (PubMed ID: 16463759)
21. Clinical and Pre-clinical Applications of the Transcendental Meditation Program in the Prevention and Treatment of Essential Hypertension and Cardiovascular Disease in Youth and Adults.
Barnes VA; Orme-Johnson DW
Curr Hypertens Rev; 2006 Aug; 2(3):207-218. PubMed ID: 22383899
[TBL] [Abstract][Full Text] [Related]
22. Design and rationale of a comparative effectiveness trial evaluating transcendental meditation against established therapies for PTSD.
Rutledge T; Nidich S; Schneider RH; Mills PJ; Salerno J; Heppner P; Gomez MA; Gaylord-King C; Rainforth M
Contemp Clin Trials; 2014 Sep; 39(1):50-6. PubMed ID: 25066921
[TBL] [Abstract][Full Text] [Related]
23. [Blood pressure goal and choice of antihypertensive treatment in patients with mild hypertensive cardiovascular disease].
Narumi H; Takano H; Komuro I
Nihon Rinsho; 2008 Aug; 66(8):1566-73. PubMed ID: 18700559
[TBL] [Abstract][Full Text] [Related]
24. [Cardiovascular system in patients in different stages of chronic kidney disease].
Strózecki P; Kozłowski M; Grajewska M; Kurowski R; Stefańska A; Odrowaź-Sypniewska G; Serafin Z; Lasek W; Nartowicz E; Kubica J; Manitius J
Pol Merkur Lekarski; 2006 Aug; 21(122):125-9; discussion 130-1. PubMed ID: 17144094
[TBL] [Abstract][Full Text] [Related]
25. Is there a role for stress management in reducing hypertension in African Americans?
Kondwani KA; Lollis CM
Ethn Dis; 2001; 11(4):788-92. PubMed ID: 11763303
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin II receptor blockers in the treatment of the cardiovascular disease continuum.
Chrysant SG
Clin Ther; 2008; 30 Pt 2():2181-90. PubMed ID: 19281913
[TBL] [Abstract][Full Text] [Related]
27. Prediction of cardiovascular morbidity and mortality: comparison of the internal carotid artery resistive index with the common carotid artery intima-media thickness.
Staub D; Meyerhans A; Bundi B; Schmid HP; Frauchiger B
Stroke; 2006 Mar; 37(3):800-5. PubMed ID: 16439703
[TBL] [Abstract][Full Text] [Related]
28. Peace through health: traditional medicine meditation in the prevention of collective stress, violence, and war.
Schneider RH; Dillbeck MC; Yeola G; Nader T
Front Public Health; 2024; 12():1380626. PubMed ID: 38633233
[TBL] [Abstract][Full Text] [Related]
29. Circulating estradiol is an independent predictor of progression of carotid artery intima-media thickness in middle-aged men.
Tivesten A; Hulthe J; Wallenfeldt K; Wikstrand J; Ohlsson C; Fagerberg B
J Clin Endocrinol Metab; 2006 Nov; 91(11):4433-7. PubMed ID: 16940451
[TBL] [Abstract][Full Text] [Related]
30. Blood pressure as a cardiovascular risk factor: prevention and treatment.
Kannel WB
JAMA; 1996 May 22-29; 275(20):1571-6. PubMed ID: 8622248
[TBL] [Abstract][Full Text] [Related]
31. Posttraumatic stress and cardiovascular disease risk.
Kibler JL
J Trauma Dissociation; 2009; 10(2):135-50. PubMed ID: 19333845
[TBL] [Abstract][Full Text] [Related]
32. Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction.
Thune JJ; Signorovitch J; Kober L; Velazquez EJ; McMurray JJ; Califf RM; Maggioni AP; Rouleau JL; Howlett J; Zelenkofske S; Pfeffer MA; Solomon SD
Hypertension; 2008 Jan; 51(1):48-54. PubMed ID: 18025296
[TBL] [Abstract][Full Text] [Related]
33. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
Oparil S; Bakir SE
Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
[TBL] [Abstract][Full Text] [Related]
34. Randomized trial of a meditation-based stress reduction program and cognitive behavior therapy in generalized social anxiety disorder.
Koszycki D; Benger M; Shlik J; Bradwejn J
Behav Res Ther; 2007 Oct; 45(10):2518-26. PubMed ID: 17572382
[TBL] [Abstract][Full Text] [Related]
35. Effect of folic acid supplementation on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials.
Qin X; Xu M; Zhang Y; Li J; Xu X; Wang X; Xu X; Huo Y
Atherosclerosis; 2012 Jun; 222(2):307-13. PubMed ID: 22209480
[TBL] [Abstract][Full Text] [Related]
36. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of the transcendental meditation program in the treatment of patients with coronary artery disease.
Zamarra JW; Schneider RH; Besseghini I; Robinson DK; Salerno JW
Am J Cardiol; 1996 Apr; 77(10):867-70. PubMed ID: 8623742
[TBL] [Abstract][Full Text] [Related]
38. Lower lipid peroxide levels in practitioners of the Transcendental Meditation program.
Schneider RH; Nidich SI; Salerno JW; Sharma HM; Robinson CE; Nidich RJ; Alexander CN
Psychosom Med; 1998; 60(1):38-41. PubMed ID: 9492237
[TBL] [Abstract][Full Text] [Related]
39. Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease.
Paul-Labrador M; Polk D; Dwyer JH; Velasquez I; Nidich S; Rainforth M; Schneider R; Merz CN
Arch Intern Med; 2006 Jun; 166(11):1218-24. PubMed ID: 16772250
[TBL] [Abstract][Full Text] [Related]
40. Meditation practices for health: state of the research.
Ospina MB; Bond K; Karkhaneh M; Tjosvold L; Vandermeer B; Liang Y; Bialy L; Hooton N; Buscemi N; Dryden DM; Klassen TP
Evid Rep Technol Assess (Full Rep); 2007 Jun; (155):1-263. PubMed ID: 17764203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
